{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:01:07Z","timestamp":1790006467758,"version":"4.0.1"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/cc-by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Chloroquine and hydroxychloroquine are 2 medications used to treat some systemic diseases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The aim of this scoping review was to assess the occurrence of oral pigmentation induced by chloroquine or hydroxychloroquine and to understand the pathogenic mechanism behind this phenomenon.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The review was performed according to the list of PRISMA SrC recommendations and the JBI Manual for Evidence Synthesis for Scoping Reviews. MEDLINE (PubMed), Scopus, EMBASE, SciELO, Web of Science, Lilacs, and LIVIVO were primary sources, and \u201cgray literature\u201d was searched in OpenThesis and Open Access Thesis and Dissertations (OATD). Studies that screened the occurrence of oral pigmentation associated to the use of chloroquine or hydroxychloroquine were considered eligible. No restrictions of year and language of publication were applied. Study selection and data extraction were performed by 2 independent reviewers. The risk of bias was assessed through the JBI tool, depending on the design of the selected studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The initial search resulted in 2238 studies, of which 19 were eligible. Sixteen studies were case reports, 2 had case-control design and 1 was cross-sectional. Throughout the studies, 44 cases of oral pigmentation were reported. The hard palate was the anatomic region most affected with pigmentation (66%). According to the case reports, most of the lesions (44%) were bluish-gray. The minimum time from the beginning of treatment (chloroquine or hydroxychloroquine) to the occurrence of pigmentation was 6 months. The mean treatment time with the medications was 4.9 years, and the mean drug dosage was 244 mg. Most of the studies (63.1%) had low risk of bias (high methodological quality).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The outcomes of this study suggest that hyperpigmentation depend on drug dosage and treatment length. Hyperpigmentation was detected after a long period of treatment with chloroquine or hydroxychloroquine.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029044","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:11:12Z","timestamp":1648732272000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Oral pigmentation as an adverse effect of chloroquine and hydroxychloroquine use"],"prefix":"10.1097","volume":"101","author":[{"given":"Pedro Urquiza Jayme","family":"Silva","sequence":"first","affiliation":[{"name":"Postgraduate Program in Dentistry, School of Dentistry, Federal University of Uberlandia, Uberl\u00e2ndia, Minas Gerais, Brazil,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millena Barroso","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Dentistry, School of Dentistry, Federal University of Uberlandia, Uberl\u00e2ndia, Minas Gerais, Brazil,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walbert","family":"Vieira","sequence":"additional","affiliation":[{"name":"Department of Restorative Dentistry, Endodontics Division, School of Dentistry of Piracicaba, State University of Campinas, UNICAMP, Piracicaba, S\u00e3o Paulo, Brazil,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio Vitorino","family":"Cardoso","sequence":"additional","affiliation":[{"name":"Division of Pathology, School of Dentistry, Federal University of Uberlandia, Uberl\u00e2ndia, Minas Gerais, Brazil,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cauane","family":"Blumenberg","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Rio Grande do Sul, Brazil,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ademir","family":"Franco","sequence":"additional","affiliation":[{"name":"Department of Dentistry, Faculdade S\u00e3o Leopoldo Mandic, Centro de Pesquisas S\u00e3o Leopoldo Mandic, Campinas, S\u00e3o Paulo, Brazil,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter Luiz","family":"Siqueira","sequence":"additional","affiliation":[{"name":"University of Saskatchewan, College of Dentistry, Saskatoon, SK, Canada,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7599-0120","authenticated-orcid":false,"given":"Luiz Renato","family":"Paranhos","sequence":"additional","affiliation":[{"name":"Division of Preventive and Community Dentistry, School of Dentistry, Federal University of Uberlandia, Uberl\u00e2ndia, Minas Gerais, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"R1-3-20250504","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2019-9-1","article-title":"Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues.","volume":"8","author":"Shukla","year":"2019","journal-title":"Drugs Context"},{"key":"R2-3-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5935\/0004-2749.20190002","article-title":"Evaluation of toxic retinopathy caused by antimalarial medications with spectral domain optical coherence tomography.","volume":"82","author":"Cabral","year":"2019","journal-title":"Arq Bras Oftalmol"},{"key":"R3-3-20250504","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41584-018-0111-8","article-title":"Hydroxychloroquine retinopathy\u2014implications of research advances for rheumatology care.","volume":"14","author":"Jorge","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R4-3-20250504","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1177\/0961203317700486","article-title":"Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases.","volume":"26","author":"Bahloul","year":"2017","journal-title":"Lupus"},{"key":"R5-3-20250504","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","article-title":"Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature.","volume":"41","author":"Chatre","year":"2018","journal-title":"Drug Saf"},{"key":"R6-3-20250504","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2020.04.024","article-title":"Characterizing the adverse dermatologic effects of hydroxychloroquine: a systematic review.","volume":"83","author":"Sharma","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R7-3-20250504","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12016-015-8469-8","article-title":"A critical review of the effects of hydroxychloroquine and chloroquine on the eye.","volume":"49","author":"Costedoat-Chalumeau","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"R8-3-20250504","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/bjo.2009.172148","article-title":"Clinical characteristics of hydroxychloroquine retinopathy.","volume":"95","author":"Payne","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R9-3-20250504","first-page":"684","article-title":"Aspects atypiques de pigmentation due aux antipaludiques de synth\u2019ese (a propos de deux cas) [atypical aspects of pigmentation due to synthetic antimalarials (apropos of 2 cases)].","volume":"71","author":"Piguet","year":"1964","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"R10-3-20250504","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/cup.12182","article-title":"Hard palate hyperpigmentation secondary to chronic chloroquine therapy: report of five cases.","volume":"40","author":"de Andrade","year":"2013","journal-title":"J Cutan Pathol"},{"key":"R11-3-20250504","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.reuma.2017.06.003","article-title":"Chloroquine-induced oral mucosal hyperpigmentation and nail dyschromia. Hiperpigmentaci\u00f3n de la mucosa oral y discrom\u00eda ungueal inducida por cloroquina.","volume":"14","author":"Horta-Baas","year":"2018","journal-title":"Reumatol Clin"},{"key":"R12-3-20250504","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/0961203320922620","article-title":"Oral manifestations associated with antimalarial therapy in patients with systemic lupus erythematosus.","volume":"29","author":"Chac\u00f3n-Dulcey","year":"2020","journal-title":"Lupus"},{"key":"R13-3-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R14-3-20250504","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation.","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"R16-3-20250504","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework.","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol Theory Pract"},{"key":"R17-3-20250504","article-title":"Aromataris E, Munn Z, et al. Chapter 7: Systematic reviews of etiology and risk.","author":"Moola","year":"2020","journal-title":"JBI Manual for Evidence Synthesis"},{"key":"R18-3-20250504","first-page":"185","article-title":"Hyperpigmentation and retinopathy caused by chloroquine diphosphate.","volume":"151","author":"Langhof","year":"1965","journal-title":"Dermatol Wochenschr"},{"key":"R19-3-20250504","first-page":"735","article-title":"Cloroquine-induced pigmentation: case reports.","volume":"62","author":"Levy","year":"1982","journal-title":"South African Med J"},{"key":"R20-3-20250504","first-page":"36","article-title":"Oral mucosal hyperpigmentation caused by lingering use of antimalarial drug.","volume":"44","author":"Silveira","year":"2003","journal-title":"R Fac Odontol"},{"key":"R21-3-20250504","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1111\/j.1365-2230.2008.03185.x","article-title":"Druginduced pigmentation of hard palate and skin due to chronic chloroquine therapy: report of two cases.","volume":"34","author":"Gallo","year":"2009","journal-title":"Clin Experiment Dermatol"},{"key":"R22-3-20250504","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/15569527.2010.521225","article-title":"Antimalarial cutaneous side effects: a study in 209 users.","volume":"30","author":"Skare","year":"2011","journal-title":"Cutan Ocul Toxicol"},{"key":"R23-3-20250504","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12105-011-0288-5","article-title":"Palate hyperpigmentation caused by prolonged use of the anti-malarial chloroquine.","volume":"6","author":"de Melo Filho","year":"2012","journal-title":"Head and Neck Pathol"},{"key":"R24-3-20250504","first-page":"921","article-title":"Isolated hyperpigmentation of the oral mucosa due to hydroxychloroquine.","volume":"10","author":"Kalampalikis","year":"2012","journal-title":"JDDG"},{"key":"R25-3-20250504","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1051\/mbcb\/2012016","article-title":"Pigmentation palatine due \u00e0 la chloroquine persistant apr\u00e8s plus de 50 ans?","volume":"18","author":"Martinelli-Kl\u00e4y","year":"2012","journal-title":"Chirurgie Buccale"},{"key":"R26-3-20250504","first-page":"935","article-title":"Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a casecontrol study.","volume":"149","author":"Jallouli","year":"2013","journal-title":"JAMA"},{"key":"R27-3-20250504","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4274\/tdd.2270","article-title":"Cutaneous hyperpigmentation during therapy with hydroxychloroquine.","volume":"3","author":"Takci","year":"2015","journal-title":"Turk J Dermatol"},{"key":"R28-3-20250504","first-page":"e1487","article-title":"Hyperpigmentation of hard palate induced by chloroquine therapy.","volume":"9","author":"de Andrade","year":"2017","journal-title":"J Clin Exp Dent"},{"key":"R29-3-20250504","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/art.40327","article-title":"Hard palate hyperpigmentation\u2014a rare side effect of antimalarials.","volume":"70","author":"Manger","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R30-3-20250504","first-page":"e54","article-title":"Drug-associated hyperpigmentation of the oral mucosa: report of four cases.","volume":"125","author":"Tosios","year":"2018","journal-title":"Oral Maxillofac Pathol"},{"key":"R31-3-20250504","first-page":"48","article-title":"A pigmented palate\u2014hydroxychloroquine-related oral hyperpigmentation.","author":"Ladan","year":"2019","journal-title":"J Oral Pathol Med"},{"key":"R32-3-20250504","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1111\/bcp.14313","article-title":"Extensive hard palate hyperpigmentation associated with chloroquine use.","volume":"86","author":"Godinho","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"R33-3-20250504","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00002018-199308040-00004","article-title":"Adverse effects of antimalarials. An Update.","volume":"8","author":"Luzzi","year":"1993","journal-title":"Drug Saf"},{"key":"R34-3-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-2952(92)90661-2","article-title":"Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum.","volume":"43","author":"Krogstad","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"R35-3-20250504","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today\u2019s diseases.","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"R36-3-20250504","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1191\/0961203306lu2299oa","article-title":"Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients.","volume":"15","author":"Wozniacka","year":"2006","journal-title":"Lupus"},{"key":"R37-3-20250504","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"R38-3-20250504","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.","author":"Cortegiani","year":"2020","journal-title":"J Crit Care"},{"key":"R39-3-20250504","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2019014","article-title":"Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19.","author":"Cavalcanti","year":"2020","journal-title":"N Engl J Med"},{"key":"R40-3-20250504","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(20)31681-0","article-title":"Political and institutional perils of Brazil\u2019s COVID-19 crisis.","volume":"396","author":"Barberia","year":"2020","journal-title":"Lancet"},{"key":"R42-3-20250504","first-page":"760","article-title":"Brief review of chloroquine and hydroxychloroquine toxicity and management.","volume":"21","author":"Lebin","year":"2020","journal-title":"West J Emerg Med"},{"key":"R43-3-20250504","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1473-3099(07)70187-1","article-title":"Cardiotoxicity of antimalarial drugs.","volume":"7","author":"White","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"R45-3-20250504","first-page":"242","article-title":"Clinical features and management of poisoning due to antimalarial drugs.","volume":"2","author":"Jaeger","year":"1987","journal-title":"Med Toxicol Adverse Drug Exp"},{"key":"R47-3-20250504","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1600-0749.1993.tb00613.x","article-title":"Antimelanoma activity of chloroquine, an antimalarial agent with high affinity for melanin.","volume":"6","author":"Inoue","year":"1993","journal-title":"Pigment Cell Res"},{"key":"R48-3-20250504","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1021\/acs.molpharmaceut.5b00787","article-title":"Drug distribution to retinal pigment epithelium: studies on melanin binding, cellular kinetics, and single photon emission computed tomography\/computed tomography imaging.","volume":"13","author":"Rimpel\u00e4","year":"2016","journal-title":"Mol Pharm"},{"key":"R49-3-20250504","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1016\/0006-2952(82)90612-8","article-title":"Studies of the mechanism of chloroquine binding to synthetic dopa-melanin.","volume":"31","author":"Stepie\u0144","year":"1982","journal-title":"Biochem Pharmacol"},{"key":"R50-3-20250504","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/0006-2952(81)90021-6","article-title":"Studies on the binding of chlorpromazine and chloroquine to melanin in vivo.","volume":"30","author":"Tj\u00e4lve","year":"1981","journal-title":"Biochem Pharmacol"},{"key":"R51-3-20250504","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4269\/ajtmh.1945.s1-25.469","article-title":"Pigmentation of the palate and subungual tissues associated with suppressive quinacrine hydrochloride therapy.","volume":"25","author":"Lippard","year":"1945","journal-title":"Am J Trop Med Hyg"},{"key":"R52-3-20250504","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4317\/medoral.17679","article-title":"Oral pigmented lesions: clinicopathologic features and review of the literature.","volume":"17","author":"Gondak","year":"2012","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"R53-3-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/moe.2000.106340","article-title":"Oral mucosal hyperpigmentation secondary to antimalarial drug therapy.","volume":"90","author":"Kleinegger","year":"2000","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R54-3-20250504","first-page":"327","article-title":"Pigmented lichenoid drug eruption secondary to chloroquine therapy: an unusual presentation in lower lip.","volume":"60","author":"Moraes","year":"2011","journal-title":"Minerva Stomatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:23:46Z","timestamp":1746332626000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029044"}},"subtitle":["A scoping review"],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029044","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"2021-01-04 2022-02-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}